cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
BioRegenEx · Research

Exosome Research Library: Published MSC Exosome Studies

← Back to Research Library
About this library. A curated, regularly updated index of 234 published, peer-reviewed studies and reviews on mesenchymal stem cell (MSC)-derived exosomes, compiled from PubMed (National Library of Medicine) for research and educational use. Human clinical studies are listed first in each category and marked [HUMAN STUDY]; most other entries are preclinical (laboratory or animal) studies or reviews. Each entry links to its PubMed record. Studies are organized by clinical application — choose a category to jump to that section.
Browse by category:

Skin, Wound & Hair (28 studies)

MSC-derived exosomes in skin and subcutaneous tissue diseases (review)
Dairov A, et al. · Curr Stem Cell Res Ther · 2026 · PubMed · DOI
Exosomes for hair growth and regeneration
J Biosci Bioeng · 2024 · Review · PubMed
Exosomal microRNA-based therapies for skin diseases (review)
Jibing C, et al. · Regen Ther · 2023 · PubMed · DOI
MSCs and their exosomes in skin wound healing: a comprehensive review
Bian D, et al. · Stem Cell Res Ther · 2022 · PubMed · DOI

↑ Back to categories

Osteoarthritis (8 studies)

Human umbilical cord MSC-derived exosomes in rat osteoarthritis models
Yang H, et al. · Stem Cells Transl Med · 2024 · PubMed · DOI

↑ Back to categories

Orthopedic & Cartilage (6 studies)

MSC-based therapy for cartilage regeneration in knee osteoarthritis
Xiang XN, et al. · Stem Cell Res Ther · 2022 · PubMed · DOI

↑ Back to categories

Bone & Joint (6 studies)

↑ Back to categories

Tendon & Ligament (7 studies)

↑ Back to categories

Spinal Cord (8 studies)

↑ Back to categories

Spine & Disc (2 studies)

↑ Back to categories

Neurological (39 studies)

Exosome Therapy for Stroke
Stroke · 2018 · Review · PubMed
MSC therapy in intracerebral haemorrhagic stroke (review)
Bedini G, et al. · Curr Med Chem · 2018 · PubMed · DOI

↑ Back to categories

Peripheral Nerve (6 studies)

↑ Back to categories

Mental Health (2 studies)

↑ Back to categories

Eye & Retina (10 studies)

Regenerative treatment of ophthalmic diseases with stem cells (review)
Niu Y, et al. · Adv Ophthalmol Pract Res · 2024 · PubMed · DOI

↑ Back to categories

Hearing & ENT (6 studies)

↑ Back to categories

Respiratory & Lung (15 studies)

↑ Back to categories

Cardiovascular (13 studies)

Stem cell therapy against ischemic heart disease (review)
Tsai IT, Sun CK · Int J Mol Sci · 2024 · PubMed · DOI

↑ Back to categories

Kidney & Liver (16 studies)

↑ Back to categories

Metabolic & Diabetic (9 studies)

Adipose-derived MSC therapy as a new treatment option for diabetes mellitus (review)
Mikłosz A, Chabowski A · J Clin Endocrinol Metab · 2023 · PubMed · DOI

↑ Back to categories

Gut & IBD (8 studies)

↑ Back to categories

Immunology (3 studies)

↑ Back to categories

Immune & GVHD (7 studies)

↑ Back to categories

Rheumatoid & Autoimmune (4 studies)

↑ Back to categories

Sepsis & Critical Care (1 studies)

Mesenchymal stem cell-derived exosomes for treatment of sepsis
Homma K, et al. · Front Immunol · 2023 · PubMed · DOI

↑ Back to categories

Cancer Biology (6 studies)

↑ Back to categories

Reproductive Health (3 studies)

↑ Back to categories

Urology & Men’s Health (7 studies)

↑ Back to categories

Muscle (2 studies)

↑ Back to categories

Dental & Oral (3 studies)

↑ Back to categories

Aging & Senescence (1 studies)

↑ Back to categories

Drug Delivery & Engineering (2 studies)

↑ Back to categories

Methods & Characterization (1 studies)

↑ Back to categories

Reviews & Overviews (5 studies)

↑ Back to categories

This library is educational. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.